Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion

Clinical and Experimental Nephrology

Volumn 8, Issue 1, 2004, Pages 17-26

  Tomita, Masayuki ^a   Koike, Hiroko ^a   Han, Gi Dong ^a   Shimizu, Fujio ^a   Kawachi, Hiroshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Monoclonal antibody 1 22 3; Thy 1.1 glomerulonephritis; Tissue inhibitor of metalloproteinase 1; Type I collagen; Type IV collagen

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGENASE 3; GELATINASE A; GELATINASE B; MARKER; MATRIX METALLOPROTEINASE; MESSENGER RNA; MONOCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; MESANGIUM CELL; NONHUMAN; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, THY-1; BIOLOGICAL MARKERS; COLLAGEN; COLLAGEN TYPE I; COLLAGEN TYPE IV; COLLAGENASES; COMPUTER SYSTEMS; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PROTEINURIA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 1942453449     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-003-0258-7     Document Type: Article

References (32)

1. Hricik DE, Chung-Park M, Sedor JR. Glomerulonephritis. N Engl J Med 1998;339:888-99.
2. Jefferson JA, Johnson RJ. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 1999;12:297-307.
3. Lenz O, Elliot SJ, Stetler-Stevenson WG. Matrix metalloproeinases in renal development and disease. J Am Soc Nephrol 2000;11:574-81.
4. Nakayama H, Oite T, Kawachi H, Morioka T, Kobayashi H, Orikasa M, et al. Comparative nephritogenicity of two monoclonal antibodies that recognize different epitopes of rat Thy-1.1 molecule. Nephron 1998;78:453-63.
5. Yagi M, Yamamoto T, Kato S, Nagano N, Kihara I. Long-term observation of glomerulonephritis induced by multiple injections with anti-Thy-1 antibody in rats. Pathol Int 1998;48:491-8.
6. Harendza S, Schneider A, Helmchen U, Stahl RAK. Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat. Nephrol Dial Transplant 1999;14:2873-9.
7. Kawachi H, Oite T, Shimizu F. Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3. Clin Exp Immunol 1993;92:342-6.
8. Kawachi H, Iwanaga T, Toyabe S, Oite T, Shimizu F. Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3. Clin Exp Immunol 1992;90:129-34.
9. Morita H, Maeda K, Obayashi M, Shinzato T, Nakayama A, Fujita Y, et al. Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody. Nephron 1992;60:92-9.
10. Kawachi H, Orikasa M, Matsui K, Iwanaga T, Toyabe S, Oite T, et al. Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen. Clin Exp Immunol 1992;88:399-404.
11. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, et al. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 2000;57:1949-61.
12. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137-43.
13. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, et al. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kindey Int 1991;40:477-88.
14. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in tumor model. Proc Natl Acad Sci USA 2000;97:3884-9.
15. Peters TJ, Albieri A, Bevilacque E, Chapman BM, Crane LH, Hamlin GP, Seiki M, et al. Differentiation-dependent expression of gelatinase B/matrix metalloproteinase-9 in trophoblast cells. Cell Tissue Res 1999;295:287-96.
16. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S, et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002; 277:7865-74.
17. Wells GMA, Catlin G, Cossins JA, Mangan M, Ward GA, Miller KM, et al. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 1996;18:332-40.
18. Lavaud S, Michel O, Sassy-Prigent C, Heudes D, Bazin R, Bariéty J, et al. Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. J Am Soc Nephrol 1996;7:2604-15.
19. Power WJ, Kaufman AH, Merayo-Lloves J, Arrunategui-Correa V, Foster CS. Expression of collagens I, III, IV and V mRNA in excimer wounded rat cornea: analysis by semi-quantitative PCR. Curr Eye Res 1995;14:879-86.
20. Ikezumi Y, Kawachi H, Toyabe S, Uchiyama M, Shimizu F. An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis. Kidney Int 2000;58:100-14.
21. Jacot TA, Striker GE, Stetler-Stevenson MA, Striker LJ. Mesangial calls from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen. Lab Invest 1996;75:791-9.
22. He CJ, Yang CW, Peten EP, Liu ZH, Patel A, Striker LJ, et al. Collagen and collagenase mRNAs in normal and sclerotic glomeruli: predictors of progression and response to therapy. Kidney Int 1995;47(Suppl 49):S39-43.
23. Adhikary LP, Yamamoto T, Isome M, Nakano Y, Kawasaki K, Yaoita E, et al. Expression profile of extracellular matrix and its regulatory proteins during the process of interstitial fibrosis after anti-glomerular basement membrane antibody-induced glomerular sclerosis in Sprague-Dawley rats. Pathol Int 1999;49:716-25.
24. Sürö TS, Fine LG, Shimizu F, Kitamura M. In vivo transfer of engineered macrophages into the glomerulus. Endogenous TGF-Β-mediated defense against macrophage-induced glomerular cell activation. J Immunol 1997;159:2476-83.
25. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996;97:1094-101.
26. Lelongt B, Bengatta S, Delauche M, Lund LR, Werb Z, Ronco PM. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J Exp Med 2001;193:793-802.
27. Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Maeda M, et al. Mesangial factor V expression colocalized with fibrin deposition in IgA nephropathy. Kidney Int 2000;58:598-606.
28. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 1992;267:21712-9.
29. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995;72:311-22.
30. Sato Y, Fujimoto S, Hamai K, Eto T. Metalloproteinase activity is present in rat urine and derived from the renal cortex. Nephrology 1997;3:479-86.
31. Sato Y, Fujimoto S, Hamai K, Eto T. Serial alterations of glomerular matrix-degrading metalloproteinase activity in anti-thymocyte-induced glomerulonephritis in rats. Nephron 1998;78:195-200.
32. Kaushal GP, Walker PD, Shah SV. An old enzyme with a new function: purification and characterization of a distinct matrizx-degrading metalloproteinase in rat kidney cortex and its identification as meprin. J Cell Biol 1994;126:1319-27.